A. KarimKaderMDPhD, FRCSC

PubMed

• 8 citations
  An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials.
  Juan Javier-DesLoges, Tyler J Nelson, James D Murphy, Rana R McKay, Tyler F Stewart, A Karim Kader, Ithaar Derweesh, Maria Elena Martinez, Brent S Rose> ;Urologic Oncology. 2022 May 1
• 2 citations
  Impact of age on treatment response in men with prostate cancer treated with radiotherapy.
  Alex K Bryant, Tyler J Nelson, Rana R McKay, A Karim Kader, J Kellogg Parsons, John P Einck, Christopher J Kane, Ajay P Sandhu, Arno J Mundt, James D Murphy, Brent S Rose> ;BJUI Compass. 2022 May 1
• 1 citations
  Association of Health-Care System and Survival in African American and Non-Hispanic White Patients With Bladder Cancer.
  Abhishek Kumar, Alex S Qian, Vinit Nalawade, A Karim Kader, Rana R McKay, Tyler F Stewart, Brent S Rose, Kotha, N., Qiao, E., Voora, R.> ;Journal of the National Cancer Institute. 2022 Apr 11
• 10 citations
  Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance.
  P Travis Courtney, Rishi Deka, Daniel R Cherry, Mia A Salans, Tyler J Nelson, Abhishek Kumar, Elaine Luterstein, Anthony T Yip, Vinit Nalawade, J Kellogg Parsons, A Ka...> ;Journal of the National Comprehensive Cancer Network. 2022 Feb 1
• 2 citations
  Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma-A Review.
  Arman S Walia, Randy F Sweis, Piyush K Agarwal, Andrew K Kader, Parth K Modi> ;Cancers. 2021 Dec 24
• 21 citations
  Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
  Juan Javier-Desloges, Tyler J. Nelson, James D. Murphy, Rana R. McKay, Elizabeth Pan, J Kellogg Parsons, Christopher J. Kane, A. Karim Kader, Ithaar Derweesh, Jesse No...> ;Cancer. 2021 Nov 22
• 2 citations
  Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men.
  P Travis Courtney, Rishi Deka, Daniel R Cherry, Mia A. Salans, Tyler J. Nelson, Abhishek Kumar, Elaine Luterstein, Anthony T. Yip, Vinit Nalawade, J. Kellogg Parsons, ...> ;Cancer. 2021 Aug 4
• 12 citations
  Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans.
  Abhishek Kumar, Daniel R Cherry, Patrick T Courtney, Vinit Nalawade, Paul Riviere, Jason A. Efstathiou, Rana R. McKay, A. Karim Kader, Brent S. Rose, Tyler F. Stewart> ;European Urology Open Science. 2021 Jun 9
• 6 citations
  Clarifying the Trade-Offs of Risk-Stratified Screening for Prostate Cancer: A Cost-Effectiveness Study
  Nathaniel Hendrix, Roman Gulati, Boshen Jiao, A. Karim Kader, Stephen Ryan, Ruth Etzioni> ;American Journal of Epidemiology. 2021 Oct 1
• Pathologic nodal downstaging in men with clinically involved lymph nodes undergoing radical prostatectomy: Implications for definitive locoregional therapy.
  Fady Ghali, William Daly, Moritz Hansen, Matthew H. Hayn, Jesse D. Sammon, Lisa T Beaule, Reith R Sarkar, James D. Murphy, A. Karim Kader, Ithaar Derweesh, Brent S. Ro...> ;Urologic Oncology. 2021 Feb 1
• Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical ...
  E. David Crawford, Jason Hafron, Scott T. Tagawa, Przemyslaw Twardowski, Richard G. Harris, Judd W. Moul, Thomas E. Keane, Raoul S. Concepcion, Celestia S. Higano, Luc...> ;The Journal of Urology. 2021 Feb 1
• 3 citations
  Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease.
  Reith R Sarkar, Sunil Patel, J. Kellogg Parsons, Rishi Deka, Abhishek Kumar, John P. Einck, Arno J. Mundt, A. Karim Kader, Christopher J. Kane, Paul Riviere, Rana R. M...> ;Prostate Cancer and Prostatic Diseases. 2020 Jun 8
• 6 citations
  African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance
  Rishi Deka, J. Kellogg Parsons, Daniel R. Simpson, Paul Riviere, Vinit Nalawade, Lucas K. Vitzthum, A. Karim Kader, Christopher J. Kane, Chelsea S Rock, James D. Murph...> ;Prostate Cancer and Prostatic Diseases. 2020 Apr 23
• 6 citations
  The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clin...
  E. David Crawford, Przemyslaw Twardowski, Raoul S. Concepcion, Jason Hafron, Richard G. Harris, Judd W. Moul, Lucio N. Gordan, Daniel P. Petrylak, Stuart Atkinson, Deb...> ;The Journal of Urology. 2020 Apr 1
• Low Penetrance Germline Genetic Testing: Role for Risk Stratification in Prostate Cancer Screening and Examples From Clinical Practice.
  Franklin Gaylis, Kelly K. Bree, Paul Dato, Gerald L. Andriole, Christopher J. Kane, A. Karim Kader> ;Reviews in Urology. 2020 Jan 1
• 10 citations
  Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer.
  Reith R Sarkar, Alex K. Bryant, J. Kellogg Parsons, Stephen Ryan, A. Karim Kader, Christopher J. Kane, Rana R. McKay, Ajay Sandhu, James D. Murphy, Brent S. Rose> ;European Urology Oncology. 2019 Sep 1
• 24 citations
  Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy
  Badrinath R. Konety, Neal D. Shore, Andrew Karim Kader, Sima P. Porten, Siamak Daneshmand, Tony Lough, Yair Lotan> ;European Urology. 2019 Aug 1
• 1 citations
  Germline genetics in localized prostate cancer.
  Stephen Ryan, Vi Nguyen, Kelly K. Bree, Daniel D Holst, A. Karim Kader> ;Current Opinion in Urology. 2019 Jul 1
• 42 citations
  Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
  Reith R Sarkar, J. Kellog Parsons, Alex K. Bryant, Stephen Ryan, Andrew Karim Kader, Rana R. McKay, Anthony V. D'Amico, Paul L. Nguyen, Benjamin J. Hulley, John P. Ein...> ;JAMA Internal Medicine. 2019 Jun 1
• 7 citations
  Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer
  Alex K. Bryant, Rana R. McKay, A. Karim Kader, J. Kellogg Parsons, John P. Einck, Christopher J. Kane, Arno J. Mundt, James D. Murphy, Brent S. Rose> ;International Journal of Radiation Oncology, Biology, Physics. 2019 Apr 1
• 155 citations
  NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
  Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Tracy M. Downs, Jason A. Efstathiou, Terence W. Friedlander...> ;Journal of the National Comprehensive Cancer Network. 2018 Sep 1
• 17 citations
  Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer.
  Alex K. Bryant, Andrew Karim Kader, Rana R. McKay, John P. Einck, Loren K. Mell, Arno J. Mundt, Christopher J. Kane, Jason A. Efstathiou, James D. Murphy, Brent S. Rose> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Aug 1
• 22 citations
  Change in prostate cancer presentation coinciding with USPSTF screening recommendations at a community-based urology practice.
  Franklin Gaylis, Jae Eun Choi, Zachary Hamilton, Paul Dato, Edward Cohen, Renee Calabrese, Hilary Prime, Aaron Rosenbaum, Andrew Karim Kader> ;Urologic Oncology. 2017 Nov 1
• 252 citations
  Bladder cancer, version 5.2017: Clinical practice guidelines in oncology
  Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Peter E. Clark, Tracy M. Downs, Jason A. Efstathiou, Thomas W. Flaig, Terenc...> ;Journal of the National Comprehensive Cancer Network. 2017 Oct 1
• 3 citations
  Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall
  Leili Mirsadraei, Alexey Hodkoff, Karra A. Jones, Ahmed Shabaik, A. Karim Kader, Cheryl C. Saenz, Rodolfo Montironi, David Tacha, Oluwole Fadare, Donna E. Hansel> ;Archives of Pathology & Laboratory Medicine. 2017 Aug 10
• Join now to see all